fenbendazole cancer treatment, ivermectin legal issues Alberta, alternative therapies terminal illness
BREAKING news: Our FENBENDAZOLE in Cancer Paper has been Published!
Fenbendazole has been recently taken away as an option from terminally ill cancer patients by Alberta Premier @ABDanielleSmith
- YOU MAY ALSO LIKE TO WATCH THIS TRENDING STORY ON YOUTUBE. Waverly Hills Hospital's Horror Story: The Most Haunted Room 502
who is criminalizing IVERMECTIN and FENBENDAZOLE through the Courts in Alberta.… pic.twitter.com/rJesvtFKi7
— William Makis MD (@MakisMD) August 16, 2025
BREAKING NEWS: Our FENBENDAZOLE in Cancer Paper has been Published!
The recent publication of our paper on fenbendazole in cancer treatment has sparked significant discussion in the medical community. Fenbendazole, an anti-parasitic drug commonly used in veterinary medicine, has gained attention for its potential anti-cancer properties. This development is particularly crucial for terminally ill cancer patients who are exploring all available treatment options.
In a controversial move, Alberta Premier Danielle Smith has recently restricted access to fenbendazole for these patients. Many advocates argue that this decision limits the options for those desperately seeking alternative treatments. The growing interest in fenbendazole as a potential cancer treatment has led to an increase in research, with our paper adding to the body of evidence supporting its efficacy.
Premier Smith’s actions have also drawn criticism for criminalizing the use of both ivermectin and fenbendazole in Alberta. As many patients turn to these medications as a last resort, the legal implications surrounding their use raise serious ethical questions. This situation underscores the ongoing debate about patient autonomy and the right to choose one’s treatment.
The discourse around fenbendazole and its potential benefits continues to evolve, making it essential for patients and healthcare providers alike to stay informed. For more insights on the implications of this decision, you can read the full details on the publication and the surrounding controversy here.
As we navigate these complex issues, it’s vital to discuss the science behind fenbendazole and the broader implications for cancer treatment. The medical community must work together to ensure that patients receive the best possible care and have access to the treatments they need.